Amanta Healthcare Q2 FY26: revenue up 17.3% to ₹83 Cr, net profit ₹5 Cr
Results · Finvezto · 4 Nov 2026 · Amanta Healthcare (AMANTA)
Results Q2 FY26, ₹ Cr
| Q2 FY26 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 83 | - | +17.3% |
| Operating profit | 18 | - | - |
| Net profit | 5 | - | - |
| Operating margin | 21.6% | - | - |
| Net margin | 5.8% | - | - |
YoY is the company's own figure. QoQ shows where our quarterly series matches the filing.
Key points
- For the quarter ended September 30, 2026, Amanta Healthcare Limited reported revenue of Rs 83.13 crore (up 17.3% YoY), EBITDA of Rs 17.95 crore (up 21.9% YoY), and PAT of Rs 4.86 crore compared to Rs 1.21 crore in Q2FY26. NSE filing
- SteriPort Line 3 was commissioned in September 2026 to raise SteriPort capacity by 75% to 11.6 crore bottles, expected to contribute around Rs 60 crore of revenue in FY27. NSE filing
- Revenue was ₹83 Cr, up 17.3% on a year earlier. Finvezto data
Links
NSE filing (PDF) · Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.